Michal Segal Salto

As an Associated research fellow, Michal joined the DeepCure drug discovery team in 2022. Michal has over 17 years of experience in cell biology, molecular biology, and biochemistry. She was awarded her Ph.D. from the Weizmann Institute of Science in Rehovot, Israel. In the past seven years, Michal led research groups and development processes in the preclinical and clinical stages. Michal has an in-depth understanding of relevant research, target, product identification, and the selection and experience designing product development programs. Michal has published peer-reviewed articles in high-impact factor journals and precipitated them at many international conferences.